Market Tracker

10/24 6:05pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

36.96
Data as of Oct 24
 -1.04 / -2.74%
Today’s Change
20.02
Today|||52-Week Range
42.50
+76.17%
Year-to-Date

Today’s Trading

Previous close38.00
Today’s open38.35
Day’s range36.70 - 38.38
Volume443,341
Average volume (3 months)778,199
Market cap$2.8B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-20.92%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+26.92%
P/E ratio16.4
Price/Sales3.79
Price/Book3.88

Competitors

 Today’s
change
Today’s
% change
--Cosmo Pharmaceutical...-11.95-6.38%
WXWuxi Pharmatech Caym...+0.36+0.99%
ACADACADIA Pharmaceutica...+0.67+2.55%
NPSPNPS Pharmaceuticals ...-2.15-7.39%
Data as of 4:14pm ET, 10/24/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.41
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts